People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $9.6M | $159.2M | 2012 |
Enza V. Guagenti at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Enza V. Guagenti on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Nicholson | 1 | 5 |
| RICHARD SHERMAN | 1 | 3 |
| Rosemary Mazanet | 1 | 2 |
| Dragan V. Cicic | 1 | 1 |
| Jack V. Talley | 1 | 1 |
| Rosemary V. Mazanet | 1 | 1 |
| Sergio V. Traversa | 1 | 1 |
| Dragan Cicic | 1 | 1 |
| Sandesh V. Seth | 1 | 1 |
| David V. Nicholson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.